UK markets closed

Aerie Pharmaceuticals, Inc. (AERI)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
13.23-0.10 (-0.75%)
At close: 4:00PM EDT
13.48 +0.25 (+1.89%)
After hours: 05:22PM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 5616.40M
Enterprise value 3664.05M
Trailing P/E N/A
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)6.33
Price/book (mrq)N/A
Enterprise value/revenue 37.00
Enterprise value/EBITDA 7-6.79

Trading information

Stock price history

Beta (5Y monthly) 0.94
52-week change 333.37%
S&P500 52-week change 330.48%
52-week high 321.30
52-week low 39.01
50-day moving average 313.22
200-day moving average 315.62

Share statistics

Avg vol (3-month) 3618.3k
Avg vol (10-day) 3733.57k
Shares outstanding 547.23M
Implied shares outstanding 6N/A
Float 843.55M
% held by insiders 12.50%
% held by institutions 1108.61%
Shares short (29 Sept 2021) 47.22M
Short ratio (29 Sept 2021) 47.3
Short % of float (29 Sept 2021) 415.64%
Short % of shares outstanding (29 Sept 2021) 415.29%
Shares short (prior month 30 Aug 2021) 45.02M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Jun 2021


Profit margin -175.35%
Operating margin (ttm)-142.14%

Management effectiveness

Return on assets (ttm)-22.77%
Return on equity (ttm)-663.12%

Income statement

Revenue (ttm)94.92M
Revenue per share (ttm)2.06
Quarterly revenue growth (yoy)50.80%
Gross profit (ttm)55.5M
EBITDA -99.19M
Net income avi to common (ttm)-166.44M
Diluted EPS (ttm)-3.61
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)188.29M
Total cash per share (mrq)3.99
Total debt (mrq)235.94M
Total debt/equity (mrq)N/A
Current ratio (mrq)2.67
Book value per share (mrq)-0.84

Cash flow statement

Operating cash flow (ttm)-50.19M
Levered free cash flow (ttm)-36.43M